PEMETREXED AND CARBOPLATIN VERSUS DOCETAXEL AND CARBOPLATIN AS FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED, NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Ganju, Vinod [1 ]
Pereira, Jose [2 ]
Kim, Joo-Hang [3 ]
Magallanes, Manuel [4 ]
Lee, Dae-Ho [5 ]
Wang, Jie [6 ]
Martinez, Luis [7 ]
Barraclough, Helen
Van Kooten, Maximiliano
Orlando, Mauro
机构：
[1] Frankston Private Hosp, Peninsula Oncol Ctr, Frankston, Vic, Australia
[2] Inst Arnaldo Vieira De Carvalho, Oncopneumol Dept, Sao Paulo, Brazil
[3] Yonsei Canc Ctr, Seoul, South Korea
[4] Mil Hosp Mexico, Dept Med Oncol, Mexico City, DF, Mexico
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Ulsan, South Korea
[6] Beijing Canc Hosp & Inst, Dept Thorac Oncol, Beijing, Peoples R China
[7] Natl Inst Resp Dis, Dept Oncol, Mexico City, DF, Mexico
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Pemetrexed; Docetaxel; Non-squamous nsmall cell lung cancer; Carboplatin;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S417 / S418
页数：2
相关论文
共 50 条
  • [1] A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer
    Rodrigues-Pereira, Jose
    Kim, Joo-Hang
    Magallanes, Manuel
    Lee, Dae Ho
    Wang, Jie
    Ganju, Vinod
    Martinez-Barrera, Luis
    Barraclough, Helen
    van Kooten, Maximiliano
    Orlando, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1907 - 1914
  • [2] Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer
    Aoki, Takuya
    Ebihara, Akinori
    Yogo, Yurika
    Suemasu, Keiichi
    Sakamaki, Fumio
    ONCOLOGY LETTERS, 2014, 7 (06) : 1771 - 1777
  • [3] A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
    Motohiro Tamiya
    Akihiro Tamiya
    Hiroyasu Kaneda
    Kazuhiko Nakagawa
    Kiyotaka Yoh
    Koichi Goto
    Hiroaki Okamoto
    Tsuneo Shimokawa
    Tetsuya Abe
    Hiroshi Tanaka
    Haruko Daga
    Koji Takeda
    Tomonori Hirashima
    Shinji Atagi
    Medical Oncology, 2016, 33
  • [4] A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
    Tamiya, Motohiro
    Tamiya, Akihiro
    Kaneda, Hiroyasu
    Nakagawa, Kazuhiko
    Yoh, Kiyotaka
    Goto, Koichi
    Okamoto, Hiroaki
    Shimokawa, Tsuneo
    Abe, Tetsuya
    Tanaka, Hiroshi
    Daga, Haruko
    Takeda, Koji
    Hirashima, Tomonori
    Atagi, Shinji
    MEDICAL ONCOLOGY, 2016, 33 (01) : 1 - 7
  • [5] A study of weekly docetaxel and carboplatin as first-line chemotherapy for advanced non-small cell lung cancer
    Jiang, Haiping
    Zhang, Xiaochen
    Chen, Jing
    Zhang, Ling
    Xiong, Jianping
    Zhong, Lin
    Yu, Feng
    Qian, Jiong
    Yu, Lanfang
    Wang, Xiaoting
    Shi, Genming
    Deng, Jing
    Xu, Nong
    JOURNAL OF THORACIC DISEASE, 2014, 6 (02) : 79 - 85
  • [6] An extended overall survival analysis of pemetrexed and carboplatin with or without pembrolizumab as first-line therapy for advanced non-squamous non-small cell lung cancer
    Afzal, Muhammad Zubair
    Dragnev, Konstantin H.
    Shirai, Keisuke
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [7] Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Naito, Yoshiko
    Matsuo, Norikazu
    Ishii, Hidenobu
    Tokito, Takaaki
    Azuma, Koichi
    Ichiki, Masao
    Hoshino, Tomoaki
    ANTICANCER RESEARCH, 2018, 38 (06) : 3779 - 3784
  • [8] Phase I Study of Carboplatin Combined with Pemetrexed for Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Azuma, Koichi
    Zaizen, Yoshiaki
    Yamashita, Fumie
    Yoshida, Tsukasa
    Naito, Yoshiko
    Okayama, Yusuke
    Miyamoto, Maki
    Hoshino, Tomoaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 472 - 478
  • [9] Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial
    Gervais, Radj
    Robinet, Gilles
    Clement-Duchene, Christelle
    Denis, Fabrice
    El Kouri, Claude
    Martin, Philippe
    Chouaki, Nadia
    Bourayou, Nawel
    Morere, Jean-Francois
    LUNG CANCER, 2013, 80 (02) : 185 - 190
  • [10] Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer
    Zhang, Liang
    Ou, Wei
    Liu, Qianwen
    Li, Ning
    Liu, Li
    Wang, Siyu
    THORACIC CANCER, 2014, 5 (01) : 50 - 56
12345